BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Business

  American Science and Engineering, Inc. Reports Results for Second Quarter Fiscal Year 2013 and Declares a Quarterly Dividend

  November 5, 2012

   · 

  1 min read
• Business

  StemCells Inc. Announces Webcast to Discuss Third Quarter 2012 Financial Results and Business Update

  November 5, 2012

   · 

  1 min read
• Drug Development

  Addex Therapeutics Reports Top-line Data From a Successful Phase 2a Clinical Study With ADX71149 in Schizophrenia Patients

  November 5, 2012

   · 

  10 min read
• Biotech Beach

  American Heart Association Release: Daily Doses of a New Probiotic Reduces “Bad” and Total Cholesterol

  November 5, 2012

   · 

  1 min read
• Biotech Beach

  American Heart Association Release: Infusing “Good” Cholesterol Protein May Lower Risk of Subsequent Heart Attack

  November 5, 2012

   · 

  1 min read
• Business

  Flamel Technologies Announces Third Quarter 2012 Results and Other Updates

  November 5, 2012

   · 

  11 min read
• BioCapital

  Nabi Biopharmaceuticals Announces Special Cash Dividend

  November 5, 2012

   · 

  1 min read
• Business

  Merrimack Pharmaceuticals Inc. Announces Timing of Third Quarter 2012 Investor Conference Call

  November 5, 2012

   · 

  1 min read
• Drug Development

  Ventrus Biosciences, Inc. Receives FDA Written Feedback, Targets NDA Filing for Diltiazem (VEN 307) in Anal Fissures Following Second Phase 3 Study

  November 5, 2012

   · 

  1 min read
• Business

  Progenics Pharmaceuticals, Inc. to Host Conference Call to Review Third Quarter Financial Results on November 8

  November 5, 2012

   · 

  1 min read